Archive for the ‘pharmacology’ Category

“HydroContin” on the Horizon?

For interested fans of hydrocodone (Vicodin®, Lortab®, Norco®, etc.), a private pharmaceutical company called Zogenix, Inc. is in Phase III trials of a controlled-release version of hydrocodone. In comparison, controlled-release oxycodone (OxyContin®) has been on the market since 1996. A similar formulation with hydrocodone instead of oxycodone could do wonders for patients that can’t tolerant oxycodone or other opioid drugs. Hydrocodone is sometimes known for producing less constipation than other opioids; however, it’s also known for producing more euphoria than some other opioids which could lead to the same abuse patterns we saw with OxyContin®.

When OxyContin® was released, abusers quickly found that crushing the tablet easily defeated the time-release mechanism, causing all of the oxycodone–meant for slow release over 8-12 hours–to be released into the body at once. This caused a surge in abuse of the drug in the late ’90s and well into later decades as well. Zogenix has announced that the release mechanism for its new hydrocodone formulation is the same currently used by Avinza®, a brand-name of controlled-release morphine. Other drugs using the same release mechanism include Ritalin® LA, Focalin® XR and Luvox® CR. The release mechanism is called Spheroidal Oral Drug Absorption System, or SODAS® and is licensed from Elan Drug Technologies. The SODAS® capsules contain tiny extended-release beads that release too much medication if crushed, chewed, snorted, dissolved, or injected, which will likely lead to a sharp increase in abuse of the drug much in the same manner as OxyContin®. However, for those in pain taking their medication as prescribed, it will be a welcomed addition to the pain pharmacopeia.

Under the US Controlled Substances Act, products containing “no more than 15mg of hydrocodone compounded with an NSAID or APAP” are allowed to be treated as Schedule III drugs, but hydrocodone on its own or in amounts more than 15mg are Schedule II, along with morphine, oxycodone, fentanyl, and most other opioids. Due to an additional law, there are currently no hydrocodone-only drugs on the US market today. This drug would change that.

While only in Phase III trials, the drug remains 3-5 years away.

The Truth About Tolerance

A long-experienced phenomenon, tolerance is the need to increase the dosage of medication to achieve the same effect. This is most frequently seen in illicit drug abuse. Heroin users quickly have a need to take increasing doses in order to achieve the same “high.” The same goes for other illicit drugs like amphetamines and cocaine. With most drugs tolerance is a complicated process and is not fully understood. In most cases we assume the neurotransmitters (or their receptors) affected by the specific drug type is down-regulated in some way. That is to say, if you take a lot of opioid analgesics your body reduces the amount of naturally-produced (endogenous) opioids, and also decreases the amount of opioid receptors in the body.

Some time ago, it was noticed that NMDA receptor antagonists (dissociative anesthetics) like ketamine, phencyclidine, and dextromethorphan have the side-effect of reducing the amount of tolerance formed to opioid analgesics. This has far-reaching implications because if you can mediate opioid tolerance, you can control the amount of opioid needed for pain relief.

The NMDA receptor both induces and maintains persistent enhancements of the excitability of neurons to prolonged stimulation, or “wind-up.” Wind-up is a key spinal mechanism requiring activation of the NMDA receptor that both amplifies and prolongs certain types of pain. As a result, wind-up may be one of the events underlying prolonged or chronic pain. Evidence from animal studies indicates that this mechanism is involved in the induction and maintenance of certain types of pain, most notably inflammatory and neuropathic.

Neuropathic pains are at least partly mediated by the NMDA receptor, which may relate to changes in opioid sensitivity. All opioids reduce, or with high doses block the input that causes certain types of pain, probably via activation of the presynaptic opioid receptors to prevent the release of primary afferent transmitters and so prevent pain input from actually activating the neurons that make you feel pain. However, if the pain continues, wind-up overcomes the inhibitions of input and the neurons commence firing, causing pain. As wind-up increases the activity of neurons, a higher dose of opioid will be required to block the increased excitability. Thus, at moderate doses, opioids delay wind-up without inhibiting the process itself. In contrast, NMDA antagonists abolish wind-up. Thus, threshold doses of morphine combined with low doses of NMDA antagonists are able to elicit dramatic inhibitory effects, a synergism that suggests low probability of side effects. Importantly, in a model of neuropathic pain where morphine is inoperative, the co-application of an NMDA antagonist restored the ability of morphine to inhibit the response.

All that medical speak translates to this: the pain input that’s prolonged and intensified by NMDA receptors can be delayed by opioids, but not inhibited. However, NMDA antagonists (mentioned above) completely turn off the prolongation and intensification, allowing opioids to take away that pain. Basically stated, it amounts to the aforementioned. Adding a mild NMDA receptor antagonist (in extremely sub-anesthetic doses) to an opioid enhances the effects of the opioid, allowing smaller amounts of opioid, and thus fewer side-effects.

At least there’s one good use for dextromethorphan.

Research Relieves

Recently my friend and I have been going back and forth on a campaign called ResearchSaves.org, which is a campaign that promotes medical animal testing. My friend is an avid vegetarian and PETA-type guy, and I’m a medical type guy who also enjoys steak. I don’t advocate for the needless suffering of animals, but I frequently leave comments on his blog defending animal research in certain circumstances, such as the following.

The spinal action of opioids is an excellent example of how basic research in animals can lead to improvements in the clinical relief of pain. The knowledge gained from basic animal studies showing an opioid inhibition of nociceptive spinal neurons and the direct analgesia following epidural and intrathecal opioids was soon applied to humans. Importantly, the use of various different models of clinical pain states has led to animal studies addressing the extent and mechanisms of plasticity in opioid spinal function, since pathological and physiological and pharmacological events can alter the degree of opioid antinociception. It is noteworthy that opioid receptors originally cloned from rats and mice allowed much in vivo research, and ultimately it was discovered that the animal opioid receptors are identical biochemically, and pharmacologically, to human opioid receptors.

These animals were used to develop pain and suffering relief in humans. If a couple of massively overpopulated rodent had to die for me to be pain free, I have to tell you that I’m not that upset by it.

For Your Protection

I’ve written about some pharmacology topics before, and usually they’re coherent, but this one is being written when I am rather, well, pissed off.

There’s a group of drugs called opioids, which, simply put, are drugs that behave like morphine. A lot of the general public may have taken these drugs are one point or another, such as after dental surgery. Common examples are Tylenol #3, Vicodin, Lortab, and Percocet. These drugs are all controlled under the Controlled Substances Act. There are different levels of control status, called “schedules.” Schedule I are the most tightly controlled, and Schedule V are the least controlled. What schedule a drug is placed on depends on

  1. How medically beneficial it is;
  2. How likely it is to be abused;
  3. How likely it is to cause physical dependence;
  4. How likely it is to cause psychological dependence, or addiction.

(For more information on this topic, see my rather technical piece here)

Drugs that are Schedule I are completely illegal. They’re not recognized as having any medical purpose, and they’re very likely to cause abuse, dependence, and addiction. Examples are heroin, marijuana, etc. Schedule II drugs are very tightly controlled, but can be prescribed. These drugs include highly potent opioids like morphine, methadone, oxycodone, and hydrocodone (unless combined with a non-opioid); amphetamines (used for ADD drugs), and others. Surprisingly, some drugs like methamphetamine and cocaine are Schedule II, because they have some recognized medical use. However, they’re rarely used or prescribed. Schedule III drugs are where drugs like Tylenol #3 and Vicodin fall (Percocet is still Schedule II even though it has a non-opioid). They contain a Schedule II substance, but they’re combined with a non-opioid, usually acetaminophen/APAP (Tylenol) or aspirin. Schedule III drugs are a lot easier for doctors to prescribe, because they’re not as controlled. Schedule II drugs are required by law to be locked in a separate drawer in pharmacies that stock them, and are hand delivered and tracked heavily to reduce diversion to the black market.

These Schedule III opioids like Vicodin are only Schedule III because of the combined ingredient. Well, why does that matter? Drug companies claim the acetaminophen (APAP) enhances the effects of the opioid, and so makes it so you require a lower dose of the narcotic. This has never really been proven clinically, but it is possible. But, if APAP made the opioid stronger, why is it in a schedule that has fewer controls? The real reason these drugs are combined is to deter abuse. Acetaminophen is highly toxic to the liver in overdose. So, if someone pops a dozen Vicodin to get high, the APAP that’s in those pills is going to make them really sick, by causing permanent liver damage. If someone takes a WHOLE lot, it will destroy their liver, and they will die, very, very painfully.

The thing is, people abusing these medications don’t care. They’re going to take them to get high even if it makes them sick, because they just don’t care. So now people are turning up with liver failure from abusing drugs like Vicodin. Now the FDA is considering banning all prescription drugs containing acetaminophen. Their official reasoning is that people are dumb, and they come home from the dentist with some Vicodin and pop those and then think “hey I’ll take some extra strength Tylenol too!” and that exceeds the maximum safe APAP dosage. The FDA max APAP dose per day is 4,000mg. In Europe, it’s 6,000mg. It’s never been proven what’s safe and what isn’t. It also depends on the specific users metabolism. My doctor insists I don’t take more than 2,000mg per day, which is half the legal maximum.

The thing that really gets me is that the FDA put APAP into these drugs specifically to prevent abuse by damaging the liver. Now that it’s working, they’ve decided they should ban these drugs. Who is running this shit? They’re mad at themselves. So if they ban these drugs, how will people that depend on them continue to have pain relief? For example, if a chronic pain patient taking something like Vicodin suddenly can’t get Vicodin because it’s now illegal, what are they to do? They can’t get JUST the hydrocodone component because that’s illegal in the United States. They can’t get Percocet because it would have been banned too. Their only options are to move to morphine, oxycodone, or any number of Schedule II drugs which are a lot harder to get doctors to give you (it’s hard enough to get them to give you Schedule IIIs). An interesting exception is Percodan, which is oxycodone + aspirin instead of APAP. Aspirin has its own overdose risks, including total loss of hearing.

So in summary, the FDA demanded drug companies put APAP into drugs to avoid abuse, and now they’re scolding them for causing liver failure. They’re blaming everyone else for their mistakes, including the patients. Sure, your average person that gets Vicodin three times their entire life isn’t going to lose out on this so much, but what about chronic pain patients that depend on these types of medication in order to lead a normal life. People like me.

Acetaminophen is over-the-counter. Anyone can grab a bottle and overdose, but we need to worry about the APAP content in controlled drugs?

The mind boggles.

What is Neuropharmacology, Anyway?

This post is mostly to clarify, to journalists, what the difference between drug tolerance, drug dependence, and drug addiction is. Why does some loser like me on a tiny corner of the internet need to clarify this? Apparently, no journalists can be bothered to do any actual research.

I have read time and time again in several prominent publications that all pain medications lead to addiction. No ifs ands or buts, always. Therefore, they are dangerous and evil, we should hate them, and doctors shouldn’t prescribe them.

But who really cares? If these medicines are so widely regarded as dangerous, no one must need or use them, right? This stuff is only used by hard core junkies on the street to get high. These are the narcotics they’re always going after on COPS.

These are all excellent points. It’s too bad none of them are true.

First of all, no one uses the term “narcotic” correctly. In fact, it is so widely misused that the medical profession has completely given up. Now, “narcotic” is referred to as a legal term, and medical professionals use terms like opioids. So, what is a narcotic, really? A narcotic refers to opium, opium derivatives, and their semi-synthetic or fully synthetic substitutes. This means cocaine, meth, LSD, steroids, DXM, and yes, even marijuana are ruled out. None of these are narcotics, no matter how much the police insist upon calling them that. Why does law enforcement do this? I don’t know. Probably because “narcotic” is a scary sounding word. Opium is a milky substance produced by certain species of poppy flowers, and it contains a great many chemicals, called opiates. An opioid is any substance that binds to opioid receptors in the central nervous system (or “any substance which behaves pharmacologically like morphine”). The terms opioids and narcotics are, in essence, synonymous.

So, what are opioid receptors?

The brain works by sending messages between cells to tell those cells what to do. These messages are sent by chemicals known as neurotransmitters. Examples of neurotransmitters include melatonin, dopamine, serotonin, epinephrine (adrenaline), endorphins, and so on. Neurotransmitters that are produced directly by our bodies are referred to as endogenous ligands. These transmitters are made to fit into certain spots on the outsides of cells, like a key into a lock. These spots are called receptors. The ligand for 5HT receptors is serotonin. The ligands for (parts of) NMDA receptors include glutamate and aspartate (specifically, N-methyl D-aspartate). It is thought that all receptors have corresponding ligands, but there are several receptors we know of that we have yet to discover natural ligands for (such as the sigma receptors). A ligand for the various opioid receptors is endorphin.

(Update: A few people emailed me to let me know the ligand for sigma receptors is angeldustin. This isn’t entirely correct. The theorized ligand used to be called angeldustin, but is currently referred to as endopsychosin (never say neuroscientists don’t have a sense of humor). The reason it was called this is because PCP appears to exhibit effects on the sigma receptors, and PCP tends to make you a bit of a nut. The argument goes along the lines of “why would the brain have a natural ability to mimic the effects of PCP on the brain, and in effect make itself nutso.” Some theories of schizophrenia point at the sigma receptors. The antipsychotic drug haloperidol appears to have effects on sigma receptors. We really have absolutely no idea what they do.)

Drugs that act on the brain do so by manipulating neurotransmitters or receptors in one way or another. Some drugs prevent neurotransmitters from being produced, some prevent them from being reabsorbed, and others mimic the transmitters themselves.

In general, there are three ways that a transmitter works on a receptor. In one way, the transmitter binds to the receptor and activates it, causing changes within the cell. These transmitters are called agonists. In the second way, a transmitter binds to the receptor but doesn’t activate it, and these transmitters are called antagonists. In the third way, a transmitter binds to the receptor and partially activates it, and these are appropriately named partial agonists. One interesting property of partial agonists is that they tend to “normalize” receptor activity levels. In the presence of a low amount of neurotransmitter, the partial agonist will increase receptor function. In the presence of a high amount of neurotransmitter, however, the partial agonist will limit receptor activity. This is a type of negative feedback. The best example I can think of negative feedback is a thermostat: when it’s hot, it turns the heat off; when it’s cold, it turns the heat on.

When you take a narcotic painkiller, the drug binds to and activates various opioid receptors in the brain, spinal cord, and gastrointestinal tract. Drugs like this are opioid agonists. The opioid receptors influence many things, most notably pain and mood. Wait, the gastrointestinal tract? Yes, actually, one of their most noted side-effects is constipation, which can be severe. Opioids reduce gut motility, which means it slows down your bowels, which gives your body more time to absorb water from the bowels, which solidifies the stool. If you’ve ever taken Immodium for diarrhea, you’ve taken a very potent opioid (although, one which does not cross the blood-brain barrier and thus it is only active in the gastrointestinal tract, so it does not cause analgesia or euphoria). The effects and side-effects are enourmous and complicated, and if you’re interested in how exactly these things happen, see the Wikipedia article on opioid receptors. We’ll sum it up by saying that opioids invoke pain relief, or analgesia, feeling nice, or euphoria, and, over time, the need to increase the dosage to achieve the same effects, or drug tolerance.

The one we’re mostly concerned about is tolerance. Tolerance occurs because your brain is an amazing thing. When there are larger than normal amounts of opioids in your system for an extended period of time, the brain compensates by down-regulating the receptors. That is, it starts creating less of these receptors, so that the opioids have a lesser effect at the same dose. In order to achieve the original effects (be it analgesia or, in the case of an abuser, euphoria), the dosage must be increased so that more receptors are reached. Other than needing increasing dosages, this is not necessarily a bad thing. This is simply how the brain compensates. This is simply reality. Anyone who takes opioids for an extended period of time will experience tolerance.

So, what does this all entail? Tolerance usually implies dependence. Is this a bad thing? Maybe. Drug dependence means that your brain has become tolerant to this drug to one degree or another, and if you suddenly stop taking it, your brain chemistry is suddenly messed up. This manifests as withdrawal symptoms, which can be severe.

So wait, the journalists are right? Anyone that takes opioids for a while will go into withdrawal? Well, yes, but that doesn’t mean that you’re addicted to the drugs. This just means that, as your brain readjusts itself to the way it was before the drugs were introduced, you won’t be having a great time. This can be avoided by slowly and carefully stepping down your dosage over a period of time. By doing this, the brain adjusts slowly to each new dosage, and withdrawal is minimal or nonexistent. This means that people can take opioids for a week, a month, or even years and, so long as their dose is slowly reduced, they’ll return to their pre-opioid state just fine, and (assuming the reason for taking the drugs in the first place is gone) will be perfectly normal.

Okay, then, what is addiction? Well, many people hold somewhat personal views about this, but I’ll discuss how medical professionals view it. Addiction is defined as a psychological dependence on something. The key difference is that one is “all in their heads,” and one is physical. Whether it’s drugs, sex, food, gambling, whatever. In the case of drug addiction, someone thinks they need a particular drug in order to be normal. You can see the confusion. People who are drug dependent actually do need the drug to be normal. Drug addicts only think they do. They crave the drug. They’ll do anything to get more of it, including selling everything they own, including their bodies. Addicts will continue to do the activity despite harmful consequences to the individual’s health, mental state or social life. Addicts are usually dependent on their drug of choice, and usually experience withdrawal fairly often because of their inability to obtain their drug. This has absolutely nothing to do with addiction. There are several drugs which people may become addicted to, like marijuana, but which do not invoke drug dependence.

(Update: It is worth noting that there is a behavior that is noted as pseudo-addiction, and is defined as exhibiting addiction-like behaviors toward a drug. That is, a patient is obsessed with getting more of a drug, but not because they’re addicted. This is seen often in pain patients whose pain is not being adequately treated. Trust me, if you were in severe pain your entire life, you’d probably be pretty obsessed with obtaining pain relief. This can appear to be addiction, and, very unfortunately, many pain patients which exhibit this behavior will be marked as drug seeking and are doomed to suffer.)

So what makes people become addicted to something? No one really knows. As it is a psychological disorder, it’s hard to pin it down. Anyone can become addicted to anything at any point. The unfortunate thing is that most drugs that people are interested in developing an addiction to tend to be either controlled or illegal. This means they have to turn to the black market, and become criminals in the process. So how many people become addicts? Clinically, for people who are taking prescribed medication as it was prescribed, less than 1% of all patients become addicted. This means that, out of 1,000 pain patients, around 0-10 of those patients will experience addiction. Some people think this is unacceptable, and that it’s better to let those 990-1000 patients simply suffer.

For those of you who aren’t in pain, good for you, that’s a reasonable position to take. Pain is transient, you can tough it out, right? Except when it isn’t transient. Millions of people, including me, are in chronic pain. That means we’re in pain every minute of every day. There are many treatments for many conditions that cause this, but for millions of people the only answer to their pain is to be on opioids long-term. People have a stigma about this because they only time they hear about opioids is when someone ODs on heroin. Because of the <1% of patients, the other >90% have to suffer more. Doctors are terrified to prescribe opioids because of their psychological effects, so they’d rather not treat anyone at all. I think this is stupid, and I don’t understand how, as someone who has promised to “limit suffering,” they can do this. Sure, opioids make you feel good, and in our society that is a Bad Thing™, but for the rest of us who need them to live, please, I implore you, pull your heads out of your asses.

Return top

To Teach Pain

This is a blog by a guy that lives an ordinary life, except for living every single moment in severe pain. Chronic pain is something most people cannot understand. Pain changes everything.

This is life, in pain.